Two multicenter randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease

Ophthalmology

Volumn 107, Issue 4, 2000, Pages 631-639

  Sall, Kenneth ^a   Stevenson, Onex Dara ^b   Mundorf, Thomas K ^d   Reis, Brenda L ^c  

^a Sall Eye Surgery Center   (United States)

^b Stevenson Med and Surg Eye Center   (United States)

^c ALLERGAN INC   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CYCLOSPORIN A;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRY EYE; FEMALE; HUMAN; HYPEREMIA; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ACUITY;

CORNEA; CYCLOSPORINE; DOUBLE-BLIND METHOD; DRUG EVALUATION; DRY EYE SYNDROMES; EMULSIONS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; SAFETY; TEARS; VISUAL ACUITY;

EID: 0034105080     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)00176-1     Document Type: Article

References (26)

1. Bjerrum K.B. Keratoconjunctivitis sicca and primary Sjögren's syndrome in a Danish population aged 30-60 years. Acta Ophthalmol Scand. 75:1997;281-286.
2. Damato B.E., Allan D., Murray S.B., Lee W.R. Senile atrophy of the human lacrimal gland the contribution of chronic inflammatory disease . Br J Ophthalmol. 68:1984;674-680.
3. Hikichi T., Yoshida A., Fukui Y., et al. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol. 233:1995;555-558.
4. Schein O.D., Muñoz B., Tielsch J.M., et al. Prevalence of dry eye among the elderly. Am J Ophthalmol. 124:1997;723-728.
5. Lemp M.A. Recent developments in dry eye management. Ophthalmology. 94:1987;1299-1304.
6. Lubniewski A.J., Nelson J.D. Diagnosis and management of dry eye and ocular surface disorders. Ophthalmology Clinics of North America. 3:1990;575-594.
7. Mackie I.A., Seal D.V. Diagnostic implications of tear protein profiles. Br J Ophthalmol. 68:1984;321-324.
8. Scott I.U., Flynn H.W. Jr, Feuer W., et al. Endophthalmitis associated with microbial keratitis. Ophthalmology. 103:1996;1864-1870.
9. Seal D.V. The effect of ageing and disease on tear constituents. Trans Ophthalmol Soc UK. 104:1985;355-362.
10. Mircheff A.K., Gierow J.P., Wood R.L. Traffic of major histocompatibility complex class II molecules in rabbit lacrimal gland acinar cells. Invest Ophthalmol Vis Sci. 35:1994;3943-3951.
11. Pflugfelder S.C., Wilhelmus K.R., Osato M.S., et al. The autoimmune nature of aqueous tear deficiency. Ophthalmology. 93:1986;1513-1517.
12. Pflugfelder S.C., Jones D., Ji Z., et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 19:1999;201-211.
13. Stern M.E., Beuerman R.W., Fox R.I., et al. The pathology of dry eye the interaction between the ocular surface and lacrimal glands . Cornea. 17:1998;584-589.
14. Williamson J., Gibson A.A.M., Wilson T., et al. Histology of the lacrimal gland in keratoconjunctivitis sicca. Br J Ophthalmol. 57:1973;852-858.
15. Gao J., Schwalb T.A., Addeo J.V., et al. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca the effect of topical cyclosporin A therapy . Cornea. 17:1998;654-663.
16. Kaswan R.L., Salisbury M.A., Ward D.A. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca treatment with cyclosporine eye drops . Arch Ophthalmol. 107:1989;1210-1216.
17. Morgan R.V., Abrams K.L. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs. JAVMA. 199:1991;1043-1046.
18. Olivero D.K., Davidson M.G., English R.V., et al. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs. JAVMA. 199:1991;1039-1042.
19. Gündüz K., Özdemir Ö. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome. Acta Ophthalmol. 72:1994;438-442.
20. Laibovitz R.A., Solch S., Andriano K., et al. Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca. Cornea. 12:1993;311-323.
21. Stevenson D, Tauber J, Reis B, and the Cyclosporin A Phase 2 Study Group. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. Ophthalmology, in press.
22. ©. Arch Ophthalmol, in press.
23. Berry D. Statistical Methodology in the Pharmaceutical Sciences. 1990;464-465 M. Dekker, New York.
24. Tsubota K. Dry eye clinic for fatigued eyes. 1992;Nihonjitsugoshuponsha, Japan. [Japanese].
25. Wilson S.E., Liang Q., Kim W.-J. Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci. 40:1999;2185-2190.
26. Physician's Desk Reference. 53rd ed. Montvale, NJ: Medical Economics Company, Inc., 1999;2063.